Effect of Botulinum Toxin injection into human masseter muscle on the mandibular angle area by �씠�솕吏�
  
저작자표시-비영리-변경금지 2.0 대한민국 
이용자는 아래의 조건을 따르는 경우에 한하여 자유롭게 
l 이 저작물을 복제, 배포, 전송, 전시, 공연 및 방송할 수 있습니다.  
다음과 같은 조건을 따라야 합니다: 
l 귀하는, 이 저작물의 재이용이나 배포의 경우, 이 저작물에 적용된 이용허락조건
을 명확하게 나타내어야 합니다.  
l 저작권자로부터 별도의 허가를 받으면 이러한 조건들은 적용되지 않습니다.  
저작권법에 따른 이용자의 권리는 위의 내용에 의하여 영향을 받지 않습니다. 
이것은 이용허락규약(Legal Code)을 이해하기 쉽게 요약한 것입니다.  
Disclaimer  
  
  
저작자표시. 귀하는 원저작자를 표시하여야 합니다. 
비영리. 귀하는 이 저작물을 영리 목적으로 이용할 수 없습니다. 
변경금지. 귀하는 이 저작물을 개작, 변형 또는 가공할 수 없습니다. 
 Effect of Botulinum Toxin injection 
into human masseter muscle 
on the mandibular angle area 
 
 
 
 
Hwa Jin Lee 
 
 
 
 
 
The Graduate School 
Yonsei University 
Department of Dental Science 
  
Effects of Botulinum Toxin injection 
 into human masseter muscle  
on the mandibular angle area 
 
Directed by Professor HYOUNG-SEON BAIK 
 
 
The Doctor’s Thesis 
Submitted to the Department of Dental Science 
and the Graduate School of Yonsei University 
in partial fulfillment of the requirements for the degree of 
 Doctor of Dental Science  
 
Hwa Jin Lee 
June 2015 
   
 감사의 글 
 
 
논문이 완성되기까지 항상 아낌없는 지도와 격려로 이끌어주신 백형선 지
도 교수님께 진심으로 감사 드립니다. 실험을 위해 소중한 도움을 주신 김
성택 교수님께도 감사 드립니다. 또한 많은 관심과 조언으로 심사를 맡아
주신 유형석 교수님, 김기덕 교수님, 이기준 교수님께 진심으로 감사 드립
니다. 
특히 바쁜 와중에도 실험을 위해 귀중한 시간을 내어 많은 도움을 준 이홍
희 선생에게 깊이 감사합니다.  
늘 걱정하시는 부모님과 가족들께 사랑하는 마음 전합니다. 멀리 있어서 
자주 보지 못하지만 항상 응원을 아끼지 않는 동생과 논문을 위해 소중한 
도움을 준 제부에게도 감사의 마음을 보냅니다.  
옆에서 항상 용기를 북돋아주는 우리 가족들에게도 고마운 마음과 사랑을 
전합니다. 
 
 
 
 
2015 년 5 월 
이 화 진
i 
TABLE OF CONTENTS 
 
 
LIST OF TABLES ····································································· ii 
LIST OF FIGURES ··································································· iii 
ABSTRACT ············································································iv 
I. INTRODUCTION ··································································· 1 
II. SUBJECTS AND METHODS ···················································· 4 
1. Subjects ············································································ 4 
  2. Methods ··········································································· 5 
  1) BoNT injection ····························································· 5 
      2) Three dimensional cone beam computed tomography taking ········ 5 
  3) 3D measurement 
A. Masseter muscle thickness and cross sectional area ··············· 6 
B. Width of mandibular angle area ······································ 8 
C. Volume of mandibular angle area ···································· 9 
      4) Statistical analysis ························································ 11 
III. RESULTS ········································································· 11 
IV. DISCUSSION ···································································· 15 
V. CONCLUSION ···································································· 19 
VI. REFERENCES ··································································· 20 
 
ABSTRACT (KOREAN) ···························································· 23
ii 
LIST OF TABLES 
 
 
Table 1. Mean changes of masseter muscle thickness ···························· 11 
 
Table 2. Mean changes of masseter muscle cross sectional area ················ 12  
 
Table 3. Mean changes of width of mandibular angle area ······················ 13 
 
Table 4. Mean changes of volume of mandibular angle area ···················· 13 
 
 
 
 
 
 
 
 
iii 
LIST OF FIGURES 
 
 
Figure 1. Injection time schedule for group I and group II ······················· 4 
Figure 2. CBCT image cut level- C5, C10 ,C15 ,C20 ,C25, C30 ················ 6  
Figure 3. The volume and cross sectional area of masseter muscle at each cut 
level ·········································································· 7 
Figure 4. Reference points for width of mandibular angle area Go post (gonion 
posterius) and Go inf (gonion inferius) Widths of inter Go post Rt-Lt 
and inter Go inf Rt-Lt ······················································ 8 
Figure 5. The volume of mandibular angle area formulated by three points (Go 
inf-Go post-distal surface of mandibular second molar) ·············· 9 
 
 
  
iv 
ABSTRACT 
 
Effects of Botulinum Toxin injection 
 into human masseter muscle  
on the mandibular angle area 
 
Hwa Jin Lee 
Department of Dental Science 
The Graduate School, Yonsei University 
(Directed by Prof. HYOUNG-SEON BAIK, D.D.S., M.S.D., Ph.D.) 
 
 
 Injection of botulinum toxin type (BoNT) into masseter muscle is a noninvasive treatment 
for the masseteric hypertrophy, which is safer than the surgical treatment. Most studies 
regarding the injection of BoNT reported its effect on reducing the masseter muscle using 
ultrasonography and computed tomography. Also, it was reported that localized masticatory 
muscle atrophy after injection of BoNT alters craniofacial growth and development in animal 
studies, such as decreased ramus height, increased gonial angle. However, most of those 
studies were performed on animals, thus, the effects of BoNT injection into masseter muscle 
on the craniofacial bony structure has not been fully elucidated in humans. 
 The aim of this study was to evaluate soft and hard tissue changes on the mandibular angle 
area after injection of BoNT in patients with massetric hypertrophy using three-dimensional 
cone-beam computed tomography (3D CBCT). 
 Twenty volunteers were randomly divided into two groups. Group I (n=10) received a 
single BoNT injection into the bilateral masseter muscle, while group II (n=10) received 
v 
double BoNT injections, the second being administered 4 months after the first. Each injection 
was comprised of 25 U of BoNT.  
  3D CBCT were taken before injection and after the first injection 6 months later in two groups. 
 Thicknesses and cross-sectional areas of the masseter muscle were measured on the 6 cutting 
images of masseter muscle parallel to the mandibular plane with interval of 5 mm distance, 
which were referred to as C5, C10, C15, C20, C25, and C30. For bony changes of mandibular 
angle area, three reference points were used (Go inf, Go post, distal surface of mandibular 
second molar). Inter-gonial width (inter Go inf Rt-Lt, inter Go post Rt-Lt) were measured.  The 
bone volume of  mandibular angle formulated by 3 reference points were measured.  
 
 The results of the present study were as follows, 
1. The thicknesses and cross-sectional areas were significantly reduced in both groups 
(P<0.001), but the amount of reduction was significantly greater in group II. 
2. The intergonial width of mandibular angle area was not significantly changed in 
groups I and II (P>0.05).  
3. The bone volume of mandibular gonial angle area was significantly reduced only in 
group II (P<0.001).  
 
 BoNT injection reduced thicknesses and cross sectional areas of masseter muscle in both 
groups, but the amount of reduction were significantly greater in group II than group I. 
(P<0.05). The bone volume of mandibular angle area reduced only in group II. These finding 
demonstrate that the administration of double BoNT injections might induce change in bone 
volume at the mandibular angle area. 
 
Key words: botulnium toxin (BoNT), human masseter muscle, cone beam computed 
tomography (CBCT), mandibular angle 
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I. Introduction 
 
Both genetic and environmental factors play an important role in the craniofacial 
morphology, and Moss noted that muscle function is one of the most important epigenetic 
factors involved in guiding facial bone growth, as well as bone shape and size.1 According to 
Collins, the distinctive shape of the Inuit skull is related to vigorous chewing. Clinically, 
individuals with vigorous chewing habits have the lager muscle attachments and the lager 
mandibles.2 
Both surgical and non-surgical methods have been applied to treat the masseteric 
hypertrophy. But surgical intervention for the masseteric reduction for patients with masseteric 
２ 
hypertrophy such as external/ internal angle approach has been known to carry many risks that 
include – asymmetry, condyle fracture and inferior alveolar nerve injury. As more reversible 
and conservative methods, non surgical methods such as muscle relaxant and occlusal splints 
have been used to treat slight masseteric hypertrophy.  
 Botulnium toxin (BoNT) injection is an effective approach as a non-surgical method for 
masseteric hypertrophy. Botulium toxin produced Clostridium botulinum induces muscle 
paralysis and atrophy through the blockage of acetylcholine secretion in the neuromuscular 
junctions3,4 which is effective for striated muscles.5  BoNT is a noninvasive treatment that is 
safer than the surgical treatment for the masseteric hypertrophy. Kim et al reported that 
inducing atrophy with a BoNT injection reduces the masseter muscle in the case of masseteric 
hypertrophy6 and other study reported the effect of BoNT in reducing the masseter muscle, 
documented by ultrasonography and computed tomography.7  
Morphological changes in skeletal dimensions were demonstrated in previous studies using 
various methods to reduced muscle activity after BoNT injection.8 In those studies, it has been 
shown that induction of localized masticatory muscle atrophy with BoNT alters craniofacial 
growth and development. BoNT injection showed a typical facial morphology of a 
dolichofacial profile : a short upper face accompanied by a long lower face with extended 
mandibular length, ramus height, constricted bicoronoidal and bigonal widths.9 In adult animal 
studied, BoNT showed similar effect on mandibular bony structure, lower dentition, the 
weight of masseter, a decreased ramus height, increased gonial angle.10 However, the effects 
of a BoNT injection on the structure of the craniofacial bone to reduce muscle activity have 
not been fully investigated in human adult bone structure. 
In this study, we evaluated the effects of BoNT injection into masseter muscle on muscular 
and bony changes in the human adult mandibular angle area using three dimensional cone 
beam computed tomography (3D CBCT) images. For changes of masseter muscle, we 
３ 
measured the masseter muscle thicknesses, cross sectional areas and for bony changes of 
mandibular angle area. We measured inter gonial widths and the bone volumes of mandibular 
angle area at before and after BoNT injections. 
  
４ 
II. Subjects and Methods 
 
1. Subjects 
  
 This study population consisted of 20 volunteers who requested lower facial contouring in 
Seoul, Korea. The volunteers were randomly assigned to one of two groups: group I and group 
II. Ten volunteers (four males and six females) aged 23~40 years (mean age, 28.5 years) 
received a single BoNT injection (group I), while the remaining ten volunteers (two males and 
eight females) aged 22~48 years (mean age, 28.5 years) received double BoNT injections, the 
second being administered 4 months after the first (group II). The exclusion criteria were the 
presence of facial asymmetry and/or severe malocclusion, pregnancy and a history of any 
serious medical illnesses including drug allergy. 
 
 
 
Figure 1. Injection time schedule for group I (i.e., a single BoNT injection) and group II    
(i.e., double BoNTi njections, administered 4 months apart). Pre = preinjection. 
 
５ 
2. Methods 
 
1) BoNT injection 
 
 BoNT (Botulax, Hugel, Chuncheon, Korea) was supplied as a freeze-dried powder, 
reconstituted at a concentration of 50 U/mL (100 U in 2 mL of sterile saline), and used 
immediately. A 25U volume of BoNT was injected into the masseter muscle bilaterally using a 
1mL syringe with a 29G, 1/2-inch-long needle. Injections were performed at two points, 1 cm 
apart at the center of the lower one-third of the masseter muscle. 
 
2) Three-dimensional CBCT taking 
 
 CBCT scans (Alphard3030; Asahi Roentgen Inc., Kyoto, Japan) were performed at 6 
months before BoNT injection and after the first injection in both groups. The CBCT scans 
were obtained on the maxillofacial region for 17 seconds at a field of view of 20 cm × 17.9 cm, 
80 kVp, and 5 mA. Patients were instructed to seat in upright position with maximum 
intercuspation. The CBCT datas were converted into digital imaging and communication in 
medicine (DICOM) files at a 0.39cm slice thickness and reconstructed into 3D images using 
the InVivo Dental software program (version 5.2; Anatomage, San Jose, CA, USA). For the 
hard tissue measurements, the reconstructed image was visualized using threshold value of 
176 hounsfield unit. The mandible was separated from the whole images and the teeth above 
the alveolar bone were removed. 
  
６ 
3) 3D measurements 
 
A. Masseter muscle thickness and cross sectional area  
 
  The CBCT images of mandible were cut by 5 mm thickness parallel to mandibular plane, 
total 6 cuts. Each cutting images were named C5, C10, C15 ,C20 ,C25, C30. (Figure 2) 
Maximum thicknesses and cross sectional areas of masseter muscle were calculated at each 
CBCT images. (Figure 3)  
 
 
Figure 2. CBCT image cut level- C5, C10, C15, C20, C25, C30; mandiblular CBCT image 
were cut by 5 mm thickness parallel to mandibular plane.  
７ 
 
  
Figure 3. The thickness and cross sectional area of masseter muscle at each cutting  level : 
Blue arrow : the maximum thickness of masseter muscle 
Yellow surface : the cross sectional area of masseter muscle 
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B. Width of mandibular angle area  
 
 The following reference points were used to measure widths of mandiblular angle area: Go 
post (Gonion posterius: most posterior point of posterior border of ramus) and Go inf (Gonion 
inferius; most inferior point of inferior border of ramus).11 Widths of inter Go post Rt-Lt and 
inter Go inf Rt-Lt were measured bilaterally. 
 
   
 
Figure 4. Upper) Reference points for width of mandibular angle area :  
Go post (Goinon posterius) and Go inf (Gonion inferius) 
Lower) Widths inter Go post Rt-Lt and inter Go inf Rt-Lt . 
９ 
C. Volume of mandibular angle area   
 
 The volume of mandibular angle area formulated by three points (Go inf-Go post-distal 
surface of mandibular second molar as constant reference point) was calculated. The volumes 
within the border were measured bilaterally.  
 
 
 
Figure 5. The volume of mandibular angle area formulated by three points 
 (Go inf-Go post-distal surface of mandibular second molar) 
１０ 
4) Statistical analysis 
 
 The data was analyzed using SAS (version 9.3, SAS Institute, Cary, NC, USA) and the cut 
off for statistical significance was set at P<0.05. To evaluate reproducibility of measurements, 
all landmarks were measured twice with two weeks interval by the same person. We 
calculated  intraclass correlation coefficients.  
 In this study, we measured both left and right parts of 20 patients and included them in our 
sample. We applied the linear mixed models because there may be correlation in 
measurements between the left and right parts.  
 Wilcoxon signed rank sum test was used to compare the measurements between before and 
6 months after the first injection in two groups. Wilcoxon rank sum test was used to compare 
the measurements between two groups. 
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III. Results 
 
Table 1. Mean changes of masseter muscle thickness (mm) 
Measurements 
Group I Group II I & II 
Pre 6M 
Δ 
pre 6M 
Δ 
P † Mean S.D. p Mean S.D. p 
C5 8.00 6.59 1.41 0.88 <0.001 7.34 4.96 2.38 1.27 <0.001 <0.05 
C10 11.11 9.39 1.72 0.84 <0.001 10.76 7.57 3.19 1.24 <0.001 <0.001 
C15 13.37 11.38 1.99 0.79 <0.001 13.01 9.60 3.41 1.29 <0.001 <0.001 
C20 14.59 12.55 2.04 0.81 <0.001 14.81 11.19 3.62 1.08 <0.001 <0.001 
C25 14.99 13.11 1.88 0.71 <0.001 15.69 11.88 3.81 0.95 <0.001 <0.001 
C30 15.18 13.58 1.60 0.99 <0.001 15.81 11.92 3.90 1.14 <0.001 <0.001 
 
Δ, Change between preinjection (Pre) and 6 months after injection (6M); 
 P, comparison of the change between before and 6 months after injection(s) in each group 
 (Wilcoxon signed rank sum test);  
P†, intergroup comparison for the change between before and 6 months after injection 
 (Wilcoxon rank sum test). 
C5-30; The CBCT images of mandible were cut by 5 mm thickness parallel to mandibular plane  
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Table 2. Mean changes of masseter muscle cross sectional area (mm2) 
Measurements 
Group I Group II I & II 
pre 6M 
Δ 
pre 6M 
Δ 
P † 
Mean SD p Mean SD p 
C5 226.79 171.39 55.40 34.22 <0.001 211.50 130.24 81.26 50.68 <0.001 >0.05 
C10 35143 281.66 69.77 30.17 <0.001 342.11 224.26 117.84 52.84 <0.001 <0.05 
C15 439.57 367.70 71.88 30.17 <0.001 442.40 300.06 142.34 51.53 <0.001 <0.001 
C20 485.86 400.22 85.64 37.17 <0.001 517.11 346.99 170.12 63.97 <0.001 <0.001 
C25 495.12 413.17 81.94 33.42 <0.001 537.85 366.88 170.97 59.70 <0.001 <0.001 
C30 497.86 434.48 63.37 31.77 <0.001 538.21 372.33 165.88 56.87 <0.001 <0.001 
 
Δ, Change between preinjection (Pre) and 6 months after injection (6M); 
 P, comparison of the change between before and 6 months after injection(s) in each group 
 (Wilcoxon signed rank sum test);  
P†, intergroup comparison for the change between before and 6 months after injection 
 (Wilcoxon rank sum test). 
C5-30; The CBCT images of mandible were cut by 5 mm thickness parallel to mandibular plane  
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Table 3. Mean changes of width of mandibular angle area (mm) 
Measurements 
Group I Group II I & II 
pre 6M 
Δ 
pre 6M 
Δ 
P † 
Mean SD p Mean SD p 
Inter Go post 93.76 93.81 -0.05 0.87 >0.05 99.44 99.44 0.00 1.02 >0.05 >0.05 
Inter Go inf  91.34 91.32 0.02 0.78 >0.05 94.96 94.94 0.02 0.77 >0.05 >0.05 
 
Δ, Change between preinjection (Pre) and 6 months after injection (6M); 
 P, comparison of the change between before and 6 months after injection(s) in each group 
 (Wilcoxon signed rank sum test);  
P†, intergroup comparison for the change between before and 6 months after injection 
 (Wilcoxon rank sum test). 
 
Table 4. Mean changes of volume of mandibular angle area (mm3)  
Measurements 
Group I Group II I & II 
pre 6M 
Δ 
pre 6M 
Δ 
P † 
Mean SD p Mean SD p 
mandibular 
angle volume 
5289.65 5245.20 44.45 120.72 >0.05 6121.95 5935.05 186.90 151.97 <0.001 <0.001 
 
Δ, Change between preinjection (Pre) and 6 months after injection (6M); 
 P, comparison of the change between before and 6 months after injection(s) in each group 
 (Wilcoxon signed rank sum test);  
P†, intergroup comparison for the change between before and 6 months after injection 
 (Wilcoxon rank sum test). 
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A. Masseter muscle thickness and cross sectional area  
 
 The mean changes of the masseter muscle thickness and cross sectional area at each cutting 
level after BoNT injection are shown in table 1, 2. Masseter muscle thickness and cross 
sectional areas showed statistically significant differences between before BoNT injection and 
6 months later. The group II who received the additional injection showed more decrease than 
the group I at all cutting levels.  
 
B. Width of mandibular angle area  
 
 We measured the width of mandibular angle area before BoNT injection and 6 months later. 
We observed slight changes in the width, but it was not statistically significant in both groups 
and between two groups (Table 3).  
 
C. Volume of mandibular angle area 
 
 We measured the volume of mandibular angle area before BoNT injection and 6 months 
later. In both groups, the average volume of mandibular angle area decreased after BoNT 
injection. But the differences were statistically significant in group II while it were not in 
group I. (Table 4) 
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IV. Discussion 
 
 BoNT has been known to acts specifically on muscles without undesirable side effects. It 
blocks the potential transmission action in neuromuscular junctions by inhibiting acetylcholine 
release. The toxin dose not damage the nerves and muscle structures, so muscle function is 
restored after neutralization of the toxin.12 BoNT is rapidly (within hours), irreversibly bound 
to presynaptic neuron at the neuromuscular junction. After being internalized, it acts on a zinc-
dependent endoprotease to disrupt some of the peptides necessary for acetylcholine release. 13 
This action, which may take 2 weeks to complete, effectively destroys the affected 
neuromuscular junction, causing muscular paralysis.5  
 We demonstrated that the average of masseter muscle thicknesses and cross sectional areas 
decreased after BoNT injection, and these results were consistent with previous studies. Reduced 
muscle function decreased the muscle thickness and size. Park and et al reported that the average 
decrease of the muscle thickness was typically 18–20% of the pre-injection thickness as 
documented by  ultrasonography and CT.7, 14 Kim et al reported that the volume of the masseter 
muscle was lower after injecting of BoNT-A on each side, as documented by CT.15  
 We observed that the decrease in the muscle thickness was greater in the C20 and C30 area 
than C5. This might be because C20 and C30 areas are close to maximum height of contour of 
masseter muscle but C5 area is close to muscle attached site. 
 Most of the changes in the thickness and cross sectional areas of the masseter muscle 
appeared after 12 weeks, which is when the effect of BoNT on lower facial contouring is 
considered to peak. Shim et al reported that the average reductions in volume and thickness in 
the lower facial contour peaked at 12 weeks after injection.16 After muscle paralysis, there is 
ongoing turnover at the neuromuscular junction, although toxin exposure enhances this 
１６ 
activity such that muscular function begins to return in approximately 3 months and is usually 
completed by 6 months.5 Thus, muscle atrophy is a temporary event and new neuromuscular 
synapses can be resynthesized over a period of a few months.7 Therefore, we injected an 
additional BoNT to group II after 4 months before completely muscular function recovery for 
more consistent muscle atrophy. We observed greater decrease in thickness and cross sectional 
areas of masseter muscle in group II than in group I. Injecting the double BoNT to individuals 
with masseteric hypertrophy may be considered more effective than only one injecting.  
 We observed that there were no changes in the width of mandibular angle area after BoNT 
injection in both groups. However, we observed the change in the volume of angle area in 
group II, not group I. This result implied that there was no change in the shape of the mandible 
after single BoNT injection but repetitive BoNT injection could affect bone volume of 
mandibular angle area.  
 According to the Moss’ functional matrix theory, reduced muscle function can be  an 
epigenetic factor in the craniofacial region that affects bone structure.1 Direct and indirect 
loading such as tension or bending forces from the functioning of several muscles might 
contribute to alterations in the skeletal structure.17 Tissue degradations in bone, which underlie 
the ability of loading to maintain bone homeostasis, are induced by a combination of ground 
reaction forces and muscle contractions.18 The integral role that muscle serve to maintain bone 
health is revealed by pathologies in which muscle function is chronically altered .19,20 In acute 
conditions that result in diminished or impaired muscle function, such as bed rest or spinal 
cord injury, the annualized percentage of bone loss can range between 5% and 25%, 
depending upon skeletal site and severity of impairment.21,22 As a comparison, annual bone 
loss associated with menopause is typically reported at 2-3%.23 Chappard et al reported that 
removal of normal mechanical loading decreased the mineral content in the unit cross 
sectional area, thus altering the internal skeletal structure.24  
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 Chappard D. et al reported that bone loss assessed after BoNT injection in wistar rats.24 
Warner et al reported rapid degradations of muscle and bone in response to acute muscle 
paralysis induced by BoNT injection into hind limb muscle of murine. After BoNT injection, 
bone mineral contents and volume were diminished in hindlimb bone. In texture analysis of 
radiographs in the femur, the trabecular and cortical bone loss observed primarily via 
substantial bone resorption.19  
 The intimate physical proximity of muscle and bone suggests that biochemical factors 
released from contracting muscle (e.g., IL-6, TGF-β, TNF-α, glutamate, calcitonin gene 
related peptide(CGRP), or substance P) may also serve to enable bone homeostasis. BoNT 
reduces the full spectrum of normal muscle contractions and diminishes the release of 
biochemical factors into the local muscle-bone interactions. The diminished muscle forces 
cause the remodeling process of bone growth, which circumferentially reduces the bone 
thickness.  
 The changes of external shape and internal structure of maxilla and mandible were affected 
by various factors and oral and maxillofacial function is one of the most widely known factors. 
Van Limborgh reported that weakness of masticatory function is closely related to the 
structure of maxilla and mandible.25 Kiliaridis et al controlled masticatory force on animals 
with varying density and intensity of feed and reported differences in external shape and 
internal structure of maxilla and mandible due to changes in masticatory force.7  Matic et al. 
reported that masseter muscle function may be involved in maintaining mandibular and 
zygomatic bone through changes in bone metabolism.26  Although weakened masseter muscle 
after BoNT injection can influence maxilla and mandible, exact mechanisms and effects on 
maxilla and mandible have not been explained. Park reported using adult rats that the 
weakened masseter muscle after BoNT injection influenced the growth of mandible and 
caused changes in length and shape of mandibular angle and in trabecular pattern of bone. 27 
１８ 
 Few study has reported how BoNT injected into masseter muscle affects the shape and 
structure of mandible in human adults. Nevertheless, it could be predicted that we would 
observe the similar changes to ones in the previous study like effects of BoNT on hindlimb 
bone that observed decrease in bone mineral density, trabecular bone and cortical bone 
thickness. We observed the less change of bone than one observed by the study that used 
hindlimb bone. This might be because the amount of BoNT injection used in this study could 
not reduce masseter muscle force enough to cause a bone change in mandible.  
 This was supported by the fact that we did not observe a change in group I with single 
BoNT injection, but observed a change in the volume of angle area and further decrease in 
muscle thickness and cross sectional area in group II with additional BoNT injection. 
 According to Grimston et al, bone mineral density of hindlimb bone decreased  sharply 
during the first two or three weeks after BoNT injection.28 However, remobility and refunction 
of muscle caused  the bone mineral density to increase gradually afterwards. Bone mineral 
density increased up to 12 weeks after BoNT injection, and although it did not recover fully of 
the bone mineral density as in the before BoNT injection, they could be assumed that it 
increased further afterwards. The same recovery could be expected in the mandibular angle 
area. We would expect the bone change to last up to 12 weeks after BoNT injection when we 
observed the maximum decrease in the volume of masseter muscle. However, after the 12 
weeks, we would expect that the bony structure of maxilla and mandible would be restored to 
the original structure through normal function recovery of the masseter muscle. But this study 
analyzed CT images captured only six months after BoNT injection so it did not confirm 
changes of mandibular angle area after six months. Further study about the bone change after 
six months in both groups will be needed.  
 Moreover, a study that analyzes whether the increasing number of BoNT injections may 
lead to a greater bone loss will be needed.   
１９ 
V. Conclusion 
 
1. There were significant changes in the thickness and cross sectional area of the masseter 
muscle in the group I and II. The thickness reduced by 1.41 -2.04 mm (P<0.001) in 
group I and 2.38 -3.90 mm (P<0.001) in group II. The cross sectional area reduced by 
55.40 -85.64 mm2 (P<0.001) in group I and 81.26 -170.97 mm2 (P<0.001) in group II , 
respectively. 
2. There were no significant changes in the width of mandibular angle area in the group I 
and II.  
3. There was significant change in the volume of mandibular angle area in the group II. 
The volume of mandibular angle area reduced by 186.90mm3 (P<0.001) in group II.  
 
 BoNT injection could reduce masseter muscle thickness and cross sectional area. But the 
reductions in the thickness and cross sectional area of the masseter muscle were significantly 
greater in the group II than in the group I. (P<0.05). The volume of mandibular gonial angle 
area reduced only in group II. . These findings demonstrate that the administration of double 
BoNT injection might induce bony volume changes in the mandibular angle area. 
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보툴리눔 독소 주사의  
하악 우각부에 대한 효과 
 
 
 (지도교수: 백 형 선) 
연세대학교 대학원 치의학과 
 
 이 화 진  
 
 
보툴리눔 독소 (BoNT) 주사는 저작근 비대 환자의 치료에 있어 비교적 안전하고 
효과적인 방법이다. BoNT 주사의 저작근에 대한 효과 및 기전은 이미 알려진 바 
있고 BoNT 주사를 통해 약화된 저작근이 악안면부, 특히 하안면부에 미치는 영향 -
하악 우각부 각도의 감소, 하악지의 높이 감소 등-에 대해서도 여러 연구를 통해 
보고된 바 있다. 하지만 이들 대부분은 성장기의 동물을 대상으로 하여 BoNT 
주사가 하안면부의 성장에 미치는 영향에 관련된 연구들이었다. 
또한 저작근에 사용되는 미용 목적의 BoNT 주사는 성인이 대상인 경우가 
대부분이지만, BoNT 주사 후 약화된 저작근이 하악골의 우각 부위에 미치는 영향에 
대한 연구는 거의 보고된 바 없다. 
２４ 
이에 본 연구는 BoNT 주사가 성인의 교근과 하악 우각부의 골에 미치는 영향을 
3차원 컴퓨터 단층 촬영 영상을 통해 관찰하였다. 연구를 위하여 20명의 지원자를 
무작위로 두 군으로 나누었다. I군 (n=10)은 1회, II군 (n=10)은 2회 주사를 
시행하였는데 2차 주사는 1차 주사 4개월 후 시행하였다. 매 주사 시 사용된 
BoNT의 용량은 25U 이며 양쪽 교근에 동시에 주사하였다. I 군과 II 군 모두 BoNT 
주사 전과 6개월 후에 3차원 컴퓨터 콘빔 전산화 단층사진 (CBCT) 을 촬영하여 
3차원 영상 상에서 주사 효과를 평가하였다.  
교근에 대한 효과를 평가하기 위해 하악 평면을 기준면으로 하여 이에 평행하게 
상방 5 mm 간격으로 6개의 교근 단면 영상을 획득하였다. 각각의 단면에서 양측 
교근의 두께 및 단면적 변화를 측정하였다. 또한 우각부의 골변화를 평가하기 
위하여 양쪽 하악 우각부의 가장 후방점과 하방점을 기준점으로 사용하여 우각부간 
골의 폭경의 변화와 하악 우각부의 골 부피의 변화를 측정하여 아래와 같은 결과를 
얻었다. 
 
1. 교근의 두께 및 단면적의 유의성 있는 변화가 I 군과 II 군 모두에서 
관찰되었다.  
2. 하악 우각부간 폭경은 I군과 II군 모두에서 유의성 있는 변화가 관찰되지 
않았다. 
3. 하악 우각부의 골 부피는 II 군에서만 유의성 있게 감소하였다. (P<0.001).  
 
BoNT 주사는 교근의 두께 및 단면적의 감소를 보였고, BoNT의 반복 주사 시에 
는 그 효과는 더욱 컸으며, 반복 주사의 경우에서만 하악골 우각 부위의 골부피의 
２５ 
감소를 나타냈으며, 하악 우각부간 골의 폭경에는 변화가 없었다.  즉, 성인에서 
BoNT의 반복 주사는 교근뿐 아니라 하악골 우각 부위의 골의 부피 감소에도 
영향을 줄 수 있다. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
핵심 되는 말: 보툴리늄 독소, 교근, 3차원 콘빔 전산화 단층 촬영 (CBCT), 하악 
우각부 부피 
